Skip to main content
SpringerLink
Log in

Challenges in the Management of Hypertension in Older Populations

  • Chapter
Hypertension: from basic research to clinical practice

Part of the book series: Advances in Experimental Medicine and Biology ((AIM,volume 956))

Abstract

The prevalence of hypertension increases with age making it a significant health concern for older persons. Aging involves a range of physiological changes such as increases in arterial stiffness, widening pulse pressure, changes in renin and aldosterone levels, decreases in renal salt excretion, declining in renal function, changes in the autonomic nervous system sensitivity and function and changes to endothelial function all of which may not only affect blood pressure but may also affect individual response to pharmacotherapy used to manage hypertension and prevent end organ damage and other complications associated with poor blood pressure control.

Unlike many chronic conditions where there is limited evidence for management in older populations, there is good evidence regarding the management of hypertension in the elderly. The findings from multiple large, robust trials have provided a solid evidence-base regarding the management of hypertension in older adults, showing that reduction of blood pressure in older hypertensive populations is associated with reduced mortality and morbidity. Diuretics, agents action on the renin angiotensin system, beta blockers and calcium channel blockers have all been well studied in older populations both in view of the benefits associated with blood pressure lowering and the risks associated with associated adverse events. While all antihypertensive agents will lower blood pressure, when managing hypertension in older persons the choice of agent is dependent not only on the ability to lower blood pressure but also on the potential for harm with older persons. Understanding such potential harms in older populations is essential with older persons experiencing increased sensitivity to many of the adverse effects such as dizziness associated with the use of antihypertensive agents.

Despite the wealth of evidence regarding the benefits of managing hypertension in the old and very old, a significant proportion of older individuals with hypertension have suboptimal BP control. While there is good evidence supporting blood pressure lowering in older antihypertensive agents, these have not yet been optimally translated fully into clinical guidelines and clinical practice. There appear to be considerable differences between guidelines in terms of the guidance given to clinicians. Differences in interpretation of the evidence, as well as differences in study design and populations all contribute to differences in the guideline recommendations with respect to older populations, despite the strength of the underlying scientific evidence. Differences around who is considered “old” and what BP targets and management are considered appropriate may lead to confusion among clinicians and further contribute to the evidence-practice lag.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Alhawassi TM, Krass I, Bajorek BV, Pont LG (2014) A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clin Interv Aging 9:2079–2086

    PubMed  PubMed Central  Google Scholar 

  • Alhawassi TM, Krass I, Pont LG (2015) Prevalence, prescribing and barriers to effective management of hypertension in older populations: a narrative review. J Pharm Policy Pract 8:24

    Article  PubMed  PubMed Central  Google Scholar 

  • Barker WH, Mullooly JP, Linton KL (1998) Trends in hypertension prevalence, treatment, and control in a well-defined older population. Hypertension 31(1):552–559

    Article  CAS  PubMed  Google Scholar 

  • Barreto SM, Passos VMA, Firmo JOA, Guerra HL, Vidigal PG, Lima-Costa MFF (2001) Hypertension and clustering of cardiovascular risk factors in a community in Southeast Brazil: the Bambuí Health and Ageing Study. Arq Bras Cardiol 77(6):576–581

    Article  CAS  PubMed  Google Scholar 

  • Bates DW, Miller EB, Cullen DJ, Burdick L, Williams L, Laird N et al (1999) Patient risk factors for adverse drug events in hospitalized patients. Arch Intern Med 159(21):2553–2560

    Article  CAS  PubMed  Google Scholar 

  • Beaglehole R, Ebrahim S, Reddy S, Voûte J, Leeder S (2008) Prevention of chronic diseases: a call to action. Lancet 370(9605):2152–2157

    Article  Google Scholar 

  • Beckett N, Peters R, Tuomilehto J, Swift C, Sever P, Potter J et al (2012) Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial. BMJ 344

    Google Scholar 

  • Bond C, Raehl CL (2006) Adverse drug reactions in United States hospitals. Pharmacotherapy 26(5):601–608

    Article  CAS  PubMed  Google Scholar 

  • Bromfield SG, Bowling CB, Tanner RM, Peralta CA, Odden MC, Oparil S et al (2014) Trends in hypertension prevalence, awareness, treatment, and control among US adults 80 years and Older, 1988–2010. J Clin Hypertens 16(4):270–276

    Article  Google Scholar 

  • Bulpitt C, Beckett N, Peters R, Leonetti G, Gergova V, Fagard R et al (2011) Blood pressure control in the Hypertension in the Very Elderly Trial (HYVET). J Hum Hypertens 26(3):157–163

    Article  PubMed  CAS  Google Scholar 

  • Butt DA, Mamdani M, Austin PC, Tu K, Gomes T, Glazier RH (2013) The risk of falls on initiation of antihypertensive drugs in the elderly. Osteoporos Int 24(10):2649–2657

    Article  CAS  PubMed  Google Scholar 

  • Callisaya ML, Sharman JE, Close J, Lord SR, Srikanth VK (2014) Greater daily defined dose of antihypertensive medication increases the risk of falls in older people--a population-based study. J Am Geriatr Soc 62(8):1527–1533

    Article  PubMed  Google Scholar 

  • Carretero OA, Oparil S (2000) Essential hypertension part I: definition and etiology. Circulation 101(3):329–335

    Article  CAS  PubMed  Google Scholar 

  • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al (2003) The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289(19):2560–2571

    Article  CAS  PubMed  Google Scholar 

  • Curb JD, Borhani NO, Blaszkowski TP, Zimbaldi N, Fotiu S, Williams W (1985) Long-term surveillance for adverse effects of antihypertensive drugs. JAMA 253(22):3263–3268

    Article  CAS  PubMed  Google Scholar 

  • Daar AS, Singer PA, Persad DL, Pramming SK, Matthews DR, Beaglehole R et al (2007) Grand challenges in chronic non-communicable diseases. Nature 450(7169):494–496

    Article  CAS  PubMed  Google Scholar 

  • Dahlöf BHL, Lindholm L, Schersten B, Ekbom T, Wester P (1991) Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension). Lancet 338(8778):1281–1285

    Article  PubMed  Google Scholar 

  • Dasgupta K, Quinn RR, Zarnke KB, Rabi DM, Ravani P, Daskalopoulou SS et al (2014) The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Canadian J Cardiol 30(5):485–501

    Article  Google Scholar 

  • Davies EC, Green CF, Mottram DR, Pirmohamed M (2007) Adverse drug reactions in hospitals: a narrative review. Curr Drug Saf 2(1):79–87

    Article  PubMed  Google Scholar 

  • Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M (2009) Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One 4(2):e4439

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Department of Economic and Social Affairs United Nations (2002) World population ageing: 1950–2050. UN

    Google Scholar 

  • Devlin G (2010) Women and elderly: subgroups under-represented in clinical trials. Curr Opin Cardiol 25(4):335–339

    Article  PubMed  Google Scholar 

  • Dharmarajan TS, Dharmarajan L (2015) Tolerability of antihypertensive medications in older adults. Drugs Aging 32(10):773–796

    Article  CAS  PubMed  Google Scholar 

  • Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356(9237):1255–1259

    Article  CAS  PubMed  Google Scholar 

  • Fagard RH (2002) Epidemiology of hypertension in the elderly. Am J Geriatr Cardiol 11(1):23–28

    Article  PubMed  Google Scholar 

  • Falaschetti E, Mindell J, Knott C, Poulter N (2014) Hypertension management in England: a serial cross-sectional study from 1994 to 2011. Lancet 383(9932):1912–1919

    Article  PubMed  Google Scholar 

  • Field TS, Gurwitz JH, Harrold LR, Rothschild J, DeBellis KR, Seger AC et al (2004) Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 52(8):1349–1354

    Article  PubMed  Google Scholar 

  • Fliser D, Ritz E (1998) Relationship between hypertension and renal function and its therapeutic implications in the elderly. Gerontology 44(3):123–131

    Article  CAS  PubMed  Google Scholar 

  • Franklin SS, Gustin W, Wong ND, Larson MG, Weber MA, Kannel WB et al (1997) Hemodynamic patterns of age-related changes in blood pressure The Framingham Heart Study. Circulation 96(1):308–315

    Article  CAS  PubMed  Google Scholar 

  • Franklin SS, Jacobs MJ, Wong ND, Gilbert J, Lapuerta P (2001) Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 37(3):869–874

    Article  CAS  PubMed  Google Scholar 

  • Gambassi G, Lapane K, Sgadari A, Landi F, Carbonin P, Hume A et al (1998) Prevalence, clinical correlates, and treatment of hypertension in elderly nursing home residents. Arch Intern Med 158(21):2377–2385

    Article  CAS  PubMed  Google Scholar 

  • Gambert SR (1994) Who are the “elderly”? Geriatr Nephrol Urol 4(1):3–4

    Article  Google Scholar 

  • Gao Y, O’Caoimh R, Healy L, Kerins DM, Eustace J, Guyatt G et al (2013) Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia. BMJ Open 3(7)

    Google Scholar 

  • Gheorghiade M, Böhm M, Greene SJ, Fonarow GC, Lewis EF, Zannad F et al (2013) Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial. JAMA 309(11):1125–1135

    Article  CAS  PubMed  Google Scholar 

  • Gribbin J, Hubbard R, Gladman JR, Smith C, Lewis S (2010) Risk of falls associated with antihypertensive medication: population-based case–control study. Age Ageing:afq092

    Google Scholar 

  • Gribbin J, Hubbard R, Gladman J, Smith C, Lewis S (2011) Risk of falls associated with antihypertensive medication: self-controlled case series. Pharmacoepidemiol Drug Saf 20(8):879–884

    Article  PubMed  Google Scholar 

  • Grimshaw JM, Russell IT (1993) Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 342(8883):1317–1322

    Article  CAS  PubMed  Google Scholar 

  • Gross CP, Mallory R, Heiat A, Krumholz HM (2002) Reporting the recruitment process in clinical trials: who are these patients and how did they get there? Ann Intern Med 137(1):10–16

    Article  PubMed  Google Scholar 

  • Grossman E, Messerli FH (2006) Long-term safety of antihypertensive therapy. Prog Cardiovasc Dis 49(1):16–25

    Article  CAS  PubMed  Google Scholar 

  • Group JS (2008) Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res 31(12):2115–2127

    Article  Google Scholar 

  • Hajjar I, Kotchen TA (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 290(2):199–206

    Article  PubMed  Google Scholar 

  • Halter JB (2009) Hazzard’s geriatric medicine and gerontology. McGraw-Hill Companies

    Google Scholar 

  • Hansson LLL, Ekbom T, Dahlöf B, Lanke J, Scherstén B et al (1999) Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 354(9192):1751–1756

    Article  CAS  PubMed  Google Scholar 

  • Heiat A, Gross CP, Krumholz HM (2002) Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 162(15):1682–1688

    Article  PubMed  Google Scholar 

  • Huebschmann AD, Bublitz C, Anderson RJ (2006) Are hypertensive elderly patients treated differently? Clin Interven Aging 1(3):289

    Article  Google Scholar 

  • James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J et al (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311(5):507–520

    Article  CAS  PubMed  Google Scholar 

  • Jaques H, National Institute for H, Clinical E (2013) NICE guideline on hypertension. Eur Heart J 34(6):406–408

    Google Scholar 

  • Kannel WB, Gordan T (1978) Evaluation of cardiovascular risk in the elderly: the Framingham study. Bull N Y Acad Med 54(6):573–591

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kirkwood TB, Austad SN (2000) Why do we age? Nature 408(6809):233–238

    Article  CAS  PubMed  Google Scholar 

  • Kleman M, Dhanyamraju S, DiFilippo W (2013) Prevalence and characteristics of pseudohypertension in patients with “resistant hypertension”. J Am Soc Hypertens 7(6):467–470

    Article  PubMed  Google Scholar 

  • Kumar J (2013) Epidemiology of hypertension. Clinical Queries. Nephrology 2(2):56–61

    Google Scholar 

  • Larochelle P, Tobe SW, Lacourcière Y (2014) β-blockers in hypertension: studies and meta-analyses over the years. Can J Cardiol 30(5):S16–S22

    Article  PubMed  Google Scholar 

  • Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279(15):1200–1205

    Article  CAS  PubMed  Google Scholar 

  • Lee DS, Goeres LM (2015) Higher antihypertensive dose increases risk of falls in older people. Evid Based Nurs 18(3):96

    Article  PubMed  Google Scholar 

  • Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H et al (2013) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2224–2260

    Article  Google Scholar 

  • Lloyd-Jones DM, Evans JC, Levy D (2005) Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA 294(4):466–472

    Article  CAS  PubMed  Google Scholar 

  • Luehr DWT, Burke R, Dohmen F, Hayes R, Johnson M, Kerandi H, Margolis K, Marshall M, O’Connor P, Pereira C, Reddy G, Schlichte A, Schoenleber M (2012) Hypertension diagnosis and treatment. Institute for Clinical Systems Improvement [Internet]. Updated November 2012. Available from: http://bit.ly/Hypertension1112

  • Mackey RH, Sutton-Tyrrell K, Vaitkevicius PV, Sakkinen PA, Lyles MF, Spurgeon HA et al (2002) Correlates of aortic stiffness in elderly individuals: a subgroup of the Cardiovascular Health Study. Am J Hypertens 15(1):16–23

    Article  PubMed  Google Scholar 

  • Maclure M, Dormuth C, Naumann T, McCormack J, Rangno R, Whiteside C et al (1998) Influences of educational interventions and adverse news about calcium-channel blockers on first-line prescribing of antihypertensive drugs to elderly people in British Columbia. Lancet 352(9132):943–948

    Article  CAS  PubMed  Google Scholar 

  • MacMahon SW, Blacket RB, Macdonald GJ, Hall W (1984) Obesity, alcohol consumption and blood pressure in Australian men and women the National Heart Foundation of Australia Risk Factor Prevalence Study. J Hypertens 2(1):85–91

    Article  CAS  PubMed  Google Scholar 

  • Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M et al (2013) 2013 ESH/ESC Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34(28):2159–2219

    Article  PubMed  Google Scholar 

  • Mann SJ (1992) Systolic hypertension in the elderly: pathophysiology and management. Arch Intern Med 152(10):1977–1984

    Article  CAS  PubMed  Google Scholar 

  • Masoro EJ, Austad SN (2006) Handbook of the biology of aging. Academic press

    Google Scholar 

  • Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3(11):e442

    Article  PubMed  PubMed Central  Google Scholar 

  • Menotti A, Lanti M, Kafatos A, Nissinen A, Dontas A, Nedeljkovic S et al (2004) The role of a baseline casual blood pressure measurement and of blood pressure changes in middle age in prediction of cardiovascular and all-cause mortality occurring late in life: a cross-cultural comparison among the European cohorts of the Seven Countries Study. J Hypertens 22(9):1683–1690

    Article  CAS  PubMed  Google Scholar 

  • Mitchell GF, Parise H, Benjamin EJ, Larson MG, Keyes MJ, Vita JA et al (2004) Changes in arterial stiffness and wave reflection with advancing age in healthy men and women the Framingham Heart Study. Hypertension 43(6):1239–1245

    Article  CAS  PubMed  Google Scholar 

  • Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J (1997) The effects of initial drug choice and comorbidity on antihypertensive therapy compliance* results from a population-based study in the elderly. Am J Hypertens 10(7):697–704

    Article  CAS  PubMed  Google Scholar 

  • Moore N, Lecointre D, Noblet C, Mabille M (1998) Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 45(3):301–308

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Moser M (1998) Why are physicians not prescribing diuretics more frequently in the management of hypertension? JAMA 279(22):1813–1816

    Article  CAS  PubMed  Google Scholar 

  • Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 349(9064):1498–1504

    Article  CAS  PubMed  Google Scholar 

  • Musini VM, Tejani AM, Bassett K, Wright JM (2009) Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev 2009(4):CD000028

    Google Scholar 

  • National Heart Foundation of Australia (National Blood Pressure and Vascular Disease Advisory Committee) (2010) Guide to management of hypertension 2008. Updated December 2010. Accessed via https://heartfoundation.org.au/images/uploads/publications/HypertensionGuidelines2008to2010Update.pdf on April 15, 2016

  • Officers A, Coordinators for the ACRGTA, Lipid-Lowering Treatment to Prevent Heart Attack T (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288(23):2981–2997

    Google Scholar 

  • Ogihara T, Saruta T, Rakugi H, Matsuoka H, Shimamoto K, Shimada K et al (2010) Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hypertension 56(2):196–202

    Article  CAS  PubMed  Google Scholar 

  • Olsen H, Klemetsrud T, Stokke HP, Tretli S, Westheim A (1999) Adverse drug reactions in current antihypertensive therapy: a general practice survey of 2586 patients in Norway. Blood Press 8(2):94–101

    Article  CAS  PubMed  Google Scholar 

  • Onder G, Gambassi G, Landi F, Pedone C, Cesari M, Carbonin P et al (2001) Trends in antihypertensive drugs in the elderly: the decline of thiazides. J Hum Hypertens 15(5):291–297

    Article  CAS  PubMed  Google Scholar 

  • Onder G, Pedone C, Landi F, Cesari M, Della Vedova C, Bernabei R et al (2002) Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 50(12):1962–1968

    Article  PubMed  Google Scholar 

  • Pahor M, Carbonin P, Guralnik J, Havlik R, Furberg C (1996a) Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet 347(9008):1061–1065

    Article  CAS  PubMed  Google Scholar 

  • Pahor M, Guralnik JM, Ferrucci L, Corti M-C, Salive ME, Cerhan JR et al (1996b) Calcium-channel blockade and incidence of cancer in aged populations. Lancet 348(9026):493–497

    Article  CAS  PubMed  Google Scholar 

  • Parving H-H, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD et al (2012) Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med 367(23):2204–2213

    Article  CAS  PubMed  Google Scholar 

  • Perry HM Jr, Smith WM, McDonald RH, Black D, Cutler JA, Furberg CD et al (1989) Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study. Stroke 20(1):4–13

    Article  PubMed  Google Scholar 

  • Pimenta E, Oparil S (2012) Management of hypertension in the elderly. Nat Rev Cardiol 9(5):286–296

    Article  CAS  PubMed  Google Scholar 

  • Pinto E (2007) Blood pressure and ageing. Postgrad Med J 83(976):109–114

    Article  PubMed  PubMed Central  Google Scholar 

  • Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ et al (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329(7456):15–19

    Article  PubMed  PubMed Central  Google Scholar 

  • Prencipe M, Casini A, Santini M, Ferretti C, Scaldaferri N, Culasso F (2000) Prevalence, awareness, treatment and control of hypertension in the elderly: results from a population survey. J Hum Hypertens 14(12):825–830

    Article  CAS  PubMed  Google Scholar 

  • Primatesta P, Poulter NR (2004) Hypertension management and control among English adults aged 65 years and older in 2000 and 2001. J Hypertens 22(6):1093–1098

    Article  CAS  PubMed  Google Scholar 

  • Prince MJ, Ebrahim S, Acosta D, Ferri CP, Guerra M, Huang Y et al (2012) Hypertension prevalence, awareness, treatment and control among older people in Latin America, India and China: a 10/66 cross-sectional population-based survey. J Hypertens 30(1):177–187

    Article  CAS  PubMed  Google Scholar 

  • Psaty BM, Koepsell TD, Yanez ND, Smith NL, Manolio TA, Heckbert SR et al (1995) Temporal patterns of antihypertensive medication use among older adults, 1989 through 1992: an effect of the major clinical trials on clinical practice? JAMA 273(18):1436–1438

    Article  CAS  PubMed  Google Scholar 

  • Psaty BM, Manolio TA, Smith NL, Heckbert SR, Gottdiener JS, Burke GL et al (2002) Time trends in high blood pressure control and the use of antihypertensive medications in older adults: the Cardiovascular Health Study. Arch Intern Med 162(20):2325–2332

    Article  PubMed  Google Scholar 

  • Rai GS, Mulley GP (2007) Elderly medicine: a training guide. Elsevier Health Sciences

    Google Scholar 

  • Rejnmark L (2013) The ageing endocrine system: fracture risk after initiation of antihypertensive therapy. Nat Rev Endocrinol 9(4):189–190

    Article  CAS  PubMed  Google Scholar 

  • Rende P, Paletta L, Gallelli G, Raffaele G, Natale V, Brissa N et al (2013) Retrospective evaluation of adverse drug reactions induced by antihypertensive treatment. J Pharmacol Pharmacotherap 4(Suppl1):S47

    Google Scholar 

  • Rodriguez-Roca GC, Llisterri JL, Prieto-Diaz MA, Alonso-Moreno FJ, Escobar-Cervantes C, Pallares-Carratala V et al (2013) Blood pressure control and management of very elderly patients with hypertension in primary care settings in Spain. Hypertens Res 37(2):166–171

    Article  PubMed  CAS  Google Scholar 

  • Rouch L, Cestac P, Hanon O, Cool C, Helmer C, Bouhanick B et al (2015) Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms. CNS Drugs 29(2):113–130

    Article  CAS  PubMed  Google Scholar 

  • Sato I, Akazawa M (2013) Polypharmacy and adverse drug reactions in Japanese elderly taking antihypertensives: a retrospective database study. Drug Healthcare Patient Saf 5:143–150

    Google Scholar 

  • Schäfer H-H, De Villiers JN, Sudano I, Dischinger S, Theus G-R, Zilla P et al (2012) Recommendations for the treatment of hypertension in the elderly and very elderly–a scotoma within international guidelines. Swiss Med Wkly Epub

    Google Scholar 

  • Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M et al (2014) The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res 37(4):253–387

    Article  PubMed  Google Scholar 

  • Spranger CB, Ries AJ, Berge CA, Radford NB, Victor RG (2004) Identifying gaps between guidelines and clinical practice in the evaluation and treatment of patients with hypertension. Am J Med 117(1):14–18

    Article  PubMed  Google Scholar 

  • Stas S, Appesh L, Sowers J (2006) Metabolic safety of antihypertensive drugs: myth versus reality. Current Hypertens Rep 8(5):403–408

    Article  CAS  Google Scholar 

  • Svetkey LP, George LK, Tyroler HA, Timmons PZ, Burchett BM, Blazer DG (1996) Effects of gender and ethnic group on blood pressure control in the elderly. Am J Hypertens 9(6):529–535

    Article  CAS  PubMed  Google Scholar 

  • Talbot J, Waller P (2004) Stephens’ detection of new adverse drug reactions. Wiley, New York

    Google Scholar 

  • The World Health Organisation (2016) Projections of mortality and causes of death, 2015 and 2030. Accessed via http://www.who.int/healthinfo/global_burden_disease/projections/en/on 15 April 2016

  • Tinetti ME, Inouye SK, Gill TM, Doucette JT (1995) Shared risk factors for falls, incontinence, and functional dependence. Unifying the approach to geriatric syndromes. JAMA 273(17):1348–1353

    Article  CAS  PubMed  Google Scholar 

  • Tinetti ME, Han L, Lee DS, McAvay GJ, Peduzzi P, Gross CP et al (2014) Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. JAMA Intern Med 174(4):588–595

    Article  PubMed  PubMed Central  Google Scholar 

  • Trenkwalder P, Ruland D, Stender M, Gebhard J, Trenkwalder C, Lydtin H et al (1994) Prevalence, awareness, treatment and control of hypertension in a population over the age of 65 years: results from the Starnberg Study on Epidemiology of Parkinsonism and Hypertension in the Elderly (STEPHY). J Hypertens 12(6):709

    Article  CAS  PubMed  Google Scholar 

  • Triantafyllou A, Douma S, Petidis K, Doumas M, Panagopoulou E, Pyrpasopoulou A et al (2010) Prevalence, awareness, treatment and control of hypertension in an elderly population in Greece. Rural Remote Health 10(2):1225

    PubMed  Google Scholar 

  • Tu K, Campbell NR, Chen Z, McAlister FA (2006) Thiazide diuretics for hypertension: prescribing practices and predictors of use in 194,761 elderly patients with hypertension. Am J Geriatr Pharmacother 4(2):161–167

    Article  CAS  PubMed  Google Scholar 

  • Turnbull F, Neal B, Ninomiya T, Algert C, Arima H, Barzi F et al (2008) Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 336(7653):1121–1123

    Article  CAS  PubMed  Google Scholar 

  • Van Kraaij D, Jansen R, Gribnau F, Hoefnagels W (1998) Loop diuretics in patients aged 75 years or older: general practitioners’ assessment of indications and possibilities for withdrawal. Eur J Clin Pharmacol 54(4):323–327

    Article  PubMed  Google Scholar 

  • Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D’Agostino RB et al (2002) Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 287(8):1003–1010

    Article  PubMed  Google Scholar 

  • Wallace SM, McEniery CM, Mäki-Petäjä KM, Booth AD, Cockcroft JR, Wilkinson IB (2007) Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction. Hypertension 50(1):228–233

    Article  CAS  PubMed  Google Scholar 

  • Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG et al (2014) Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens 32(1):3–15

    Article  CAS  PubMed  Google Scholar 

  • Weinberger MH (1996) Salt sensitivity of blood pressure in humans. Hypertension 27(3):481–490

    Article  CAS  PubMed  Google Scholar 

  • Wester K, Jonsson AK, Spigset O, Druid H, Hagg S (2008) Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol 65(4):573–579

    Article  PubMed  Google Scholar 

  • White SM (2010) Including the very elderly in clinical trials. Anaesthesia 65(8):778–780

    Article  CAS  PubMed  Google Scholar 

  • White TJ, Arakelian A, Rho JP (1999) Counting the costs of drug-related adverse events. Pharmacoeconomics 15(5):445–458

    Article  CAS  PubMed  Google Scholar 

  • Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL et al (2003) A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 348(7):583–592

    Article  CAS  PubMed  Google Scholar 

  • Yang G, Kong L, Zhao W, Wan X, Zhai Y, Chen LC et al (2008) Emergence of chronic non-communicable diseases in China. Lancet 372(9650):1697–1705

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Health System and Safety Research, Australian Institute of Health Innovation, Macquarie University, North Ryde, Australia

    Lisa Pont

  2. College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

    Tariq Alhawassi

Authors
  1. Lisa Pont
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tariq Alhawassi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lisa Pont .

Editor information

Editors and Affiliations

  1. Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Stockholm, Sweden

    Md. Shahidul Islam

  2. Department of Internal Medicine and Emergency Medicine, Uppsala University Hospital, Uppsala, Sweden

    Md. Shahidul Islam

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing AG

About this chapter

Cite this chapter

Pont, L., Alhawassi, T. (2016). Challenges in the Management of Hypertension in Older Populations. In: Islam, M.S. (eds) Hypertension: from basic research to clinical practice. Advances in Experimental Medicine and Biology(), vol 956. Springer, Cham. https://doi.org/10.1007/5584_2016_149

Download citation

  • DOI: https://doi.org/10.1007/5584_2016_149

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-44250-1

  • Online ISBN: 978-3-319-44251-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation